These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3510334)

  • 1. An approach to the management of hyperlipoproteinemia.
    Hoeg JM; Gregg RE; Brewer HB
    JAMA; 1986 Jan 24-31; 255(4):512-21. PubMed ID: 3510334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of hyperlipoproteinemia].
    Drexel H; Follath F
    Schweiz Rundsch Med Prax; 1993 Apr; 82(17):506-9. PubMed ID: 8493437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of serum cholesterol/triglyceride ratio to discern for which individuals the Friedewald formula can be used confidently.
    González Estrada M; Rodríguez Ferrer CR; Astarloa IR; Lahera EM
    Clin Chem; 1990 Sep; 36(9):1673-5. PubMed ID: 2208709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New results of studies of plasma lipoprotein metabolism and the pathogenesis of hyperlipoproteinemias].
    Szollár L
    Orv Hetil; 1984 Oct; 125(43):2599-609. PubMed ID: 6493768
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the clinical biochemistry laboratory in the assessment of dyslipoproteinaemias.
    Ballantyne FC
    Ann Clin Biochem; 1984 May; 21 ( Pt 3)():166-75. PubMed ID: 6383181
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats.
    Wang D; Han J; Yu Y; Li X; Wang Y; Tian H; Guo S; Jin S; Luo T; Qin S
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1064-9. PubMed ID: 21856756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints.
    Warnick GR; Knopp RH; Fitzpatrick V; Branson L
    Clin Chem; 1990 Jan; 36(1):15-9. PubMed ID: 2297909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 14. Definition and management of hyperlipoproteinemia.
    Hoeg JM; Brewer HB
    J Am Coll Nutr; 1987 Apr; 6(2):157-63. PubMed ID: 3584735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of jejunoileoshunting on hyperlipoproteinemia in patients with pathologic obesity].
    Sedletskiĭ IuI
    Klin Khir (1962); 1985 Feb; (2):13-5. PubMed ID: 3857390
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
    J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
    J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.